PAXLOVID
Identification of Paxlovid
| No description |
Google image searchProduct monograph
Active ingredients
ritonavir, 100 MG
nirmatrelvir, 150 MG
DIN: 02524031
Dosage form(s): TABLET
Route(s) of administration: ORAL
Description: CONTAINS 5 BLISTER CARDS OF 4 NIRMATRELVIR AND 2 RITONAVIR TABLETS
Schedule: Prescription
Company: PFIZER CANADA ULC
Date: 18-JAN-2022
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AE — Protease inhibitors (ATC, ATC/DDD)
- J05AE30 — NIRMATRELVIR AND RITONAVIR (ATC/DDD)
Reference brand drug: Paxlovid
